Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Phase I
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Phase I
U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint…
Phase I
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Phase I
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Phase I
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Phase I
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
Clinical
CannTrust Announces Launch of New Medical Brand estora – FirstWord Pharma
Clinical
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA…
Phase I
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Home
Clinical
Phase I
Phase I
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase I
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021
Biospace News
-
January 11, 2021
Phase I
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium vivax malaria accepted by Australian Therapeutic Goods Administration – FirstWord Pharma
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Phase I
U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint Data to NUBEQA (darolutamide) Prescribing Information – FirstWord Pharma
Phase I
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial for ALS – FirstWord Pharma
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
January 10, 2021
0
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
January 10, 2021
0
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
January 10, 2021
0
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
January 10, 2021
0
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
January 10, 2021
0
1
2
3
...
114
Page 1 of 114
- Advertisement -
MOST POPULAR
Boehringer Ingelheim Gambles $2.62 Billion on Two Fibrotic Disease Deals
July 18, 2019
What’s New in the Biodefense Market These Days?
February 4, 2019
ReAlta Life Sciences Announces FDA Orphan Drug Designation for PIC1 for...
February 6, 2020
Aquestive Therapeutics Provides Business Update Nasdaq:AQST
January 7, 2021
Load more
HOT NEWS
Deals
Almirall signs a strategic agreement with 23andMe to license rights of...
Deals
Innovent and Sirnaomics Entered Strategic Collaboration to Conduct Clinical Oncology Studies...
Commercial
Bristol-Myers Squibb Announces Results from CheckMate -459 Study Evaluating Opdivo (nivolumab)...
Deals
Takeda Agrees to Divest Select OTC and Non-core Assets to Acino...
